Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#141 / 200 Total
USAU - U.S. Gold Corp - Stock Price Chart
TickerUSAU [NASD]
CompanyU.S. Gold Corp
CountryUSA
IndustryGold
Market Cap54.35MEPS (ttm)-0.74
P/E-EPS this Y-10.87%
Forward P/E-EPS next Y-35.29%
PEG-EPS past 5Y39.82%
P/S-EPS next 5Y-
P/B3.22EPS Q/Q20.23%
Dividend-Sales Q/Q-
Insider Own10.26%Inst Own12.21%
Insider Trans0.46%Inst Trans-1.85%
Short Float0.65%Earnings-
Analyst Recom1.00Target Price13.12
Avg Volume71.44K52W Range2.92 - 5.05
U.S. Gold Corp. engages in the exploration of gold properties. It has properties in CK Gold Project, Wyoming, Challis Gold Project, Idaho, and Keystone, Nevada. The company was founded in 1967 and is headquartered in Elko, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NORMAN LUKE ANTHONYDirectorApr 15 '24Buy4.195,00020,950348,980Apr 17 02:33 PM
AQB - AquaBounty Technologies Inc - Stock Price Chart
TickerAQB [NASD]
CompanyAquaBounty Technologies Inc
CountryUSA
IndustryFarm Products
Market Cap7.86MEPS (ttm)-7.43
P/E-EPS this Y36.82%
Forward P/E-EPS next Y31.46%
PEG-EPS past 5Y17.48%
P/S3.18EPS next 5Y-
P/B0.05EPS Q/Q-28.32%
Dividend-Sales Q/Q22.69%
Insider Own6.52%Inst Own7.29%
Insider Trans0.00%Inst Trans-74.90%
Short Float4.29%EarningsApr 01/b
Analyst Recom3.00Target Price3.00
Avg Volume20.13K52W Range1.57 - 10.60
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. It includes farming of aquatic organisms such as fish, shellfish, crustaceans, and aquatic plants. The firm focuses on a salmon product, a bioengineered Atlantic salmon that can grow to market size faster than conventional farmed Atlantic salmon. The company was founded by Elliot Z. Entis and Garth L. Fletcher on December 17, 1991 and is headquartered in Harvard, MA.
POET - POET Technologies Inc - Stock Price Chart
TickerPOET [NASD]
CompanyPOET Technologies Inc
CountryCanada
IndustrySemiconductors
Market Cap101.98MEPS (ttm)-0.50
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y2.67%
P/S216.97EPS next 5Y20.00%
P/B20.68EPS Q/Q23.53%
Dividend-Sales Q/Q-46.11%
Insider Own1.41%Inst Own15.81%
Insider Trans0.00%Inst Trans-13.57%
Short Float2.73%EarningsMar 15/a
Analyst Recom1.00Target Price3.00
Avg Volume683.22K52W Range0.72 - 5.88
POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.
MFI - mF International Ltd - Stock Price Chart
TickerMFI [NASD]
CompanymF International Ltd
CountryHong Kong
IndustrySoftware - Application
Market Cap17.36MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own68.27%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float11.57%Earnings-
Analyst Recom-Target Price-
Avg Volume2.49M52W Range1.04 - 14.49
mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022 and is headquartered in Hong Kong.
OGEN - Oragenics Inc - Stock Price Chart
TickerOGEN [AMEX]
CompanyOragenics Inc
CountryUSA
IndustryBiotechnology
Market Cap7.39MEPS (ttm)-7.90
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y29.34%
P/S184.80EPS next 5Y-
P/B3.23EPS Q/Q-356.71%
Dividend-Sales Q/Q-
Insider Own11.83%Inst Own3.57%
Insider Trans-0.66%Inst Trans28.33%
Short Float1.09%Earnings-
Analyst Recom1.00Target Price90.00
Avg Volume105.95K52W Range1.00 - 7.74
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Telling FredDirectorNov 30 '23Sale3.573,50012,48838,345Dec 01 05:23 PM
ACDC - ProFrac Holding Corp - Stock Price Chart
TickerACDC [NASD, RUT]
CompanyProFrac Holding Corp
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap1.39BEPS (ttm)-0.85
P/E-EPS this Y378.60%
Forward P/E5.95EPS next Y119.09%
PEG-EPS past 5Y-
P/S0.59EPS next 5Y-12.20%
P/B1.15EPS Q/Q-99.05%
Dividend-Sales Q/Q-31.72%
Insider Own88.55%Inst Own10.34%
Insider Trans0.00%Inst Trans1.77%
Short Float29.32%EarningsMay 09/b
Analyst Recom2.14Target Price10.58
Avg Volume1.03M52W Range6.46 - 14.32
ProFrac Holding Corp. operates as a holding company with interest in manufacturing and distribution of fracturing units & pumps and provides related services. The company was founded on August 17, 2021 and is headquartered in Willow Park, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
THRC Holdings, LP10% OwnerNov 10 '23Buy9.63630,4966,071,67672,870,545Nov 13 10:27 AM
Wilks Farris10% OwnerOct 27 '23Buy9.243,40931,516981,187Oct 31 02:49 PM
THRC Holdings, LP10% OwnerOct 17 '23Buy9.09603,4785,485,61572,240,049Oct 19 03:57 PM
THRC Holdings, LP10% OwnerJun 14 '23Buy13.40186,1482,494,38371,636,571Jun 15 05:50 PM
THRC Holdings, LP10% OwnerJun 13 '23Buy13.4198,9111,326,39771,450,423Jun 15 05:50 PM
AISP - Airship AI Holdings Inc - Stock Price Chart
TickerAISP [NASD]
CompanyAirship AI Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap139.65MEPS (ttm)0.65
P/E9.25EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S11.35EPS next 5Y-
P/B-EPS Q/Q1833.83%
Dividend-Sales Q/Q-
Insider Own54.86%Inst Own4.82%
Insider Trans0.47%Inst Trans23.09%
Short Float3.65%Earnings-
Analyst Recom-Target Price-
Avg Volume5.99M52W Range1.34 - 14.32
Airship AI Holdings, Inc. engages in a video, sensor, and data management surveillance platform, that focuses on the provision of software services. Its products include Airship Acropolis OS, Airship Command, and Airship Outpost. The company was founded in 2003, and is headquartered in Redmond, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Huang VictorCEO and Chairman of the BODJan 02 '24Buy1.4810,00014,80060,000Jan 02 08:20 PM
Huang VictorCEO and Chairman of the BODDec 29 '23Buy1.7310,00017,25050,000Jan 02 08:20 PM
Huang VictorCEO and Chairman of the BODDec 28 '23Buy2.0740,00082,86740,000Jan 02 08:20 PM
Byte Holdings LPDirector by DeputizationSep 20 '23Buy10.6370,555750,0008,662,868Sep 25 09:39 AM
Byte Holdings LPDirector by DeputizationAug 21 '23Buy10.57500,0005,285,0008,592,313Aug 21 04:30 PM
ABOS - Acumen Pharmaceuticals Inc - Stock Price Chart
TickerABOS [NASD]
CompanyAcumen Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap221.70MEPS (ttm)-1.06
P/E-EPS this Y-2.75%
Forward P/E-EPS next Y-18.63%
PEG-EPS past 5Y-54.03%
P/S-EPS next 5Y22.89%
P/B0.85EPS Q/Q9.76%
Dividend-Sales Q/Q-
Insider Own26.14%Inst Own59.27%
Insider Trans-0.22%Inst Trans4.20%
Short Float2.09%EarningsMay 14/b
Analyst Recom1.00Target Price13.50
Avg Volume317.55K52W Range1.81 - 11.31
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OConnell Daniel JosephPresident and CEOJan 19 '24Sale3.4715,20052,753502,485Jan 19 07:07 PM
Meisner Derek MChief Legal Officer & Corp SecJan 19 '24Sale3.488,93331,048108,867Jan 19 07:06 PM
Zuga MattCFO & Chief Business OfficerJan 18 '24Sale3.714,24215,717211,445Jan 19 07:05 PM
Siemers EricChief Medical OfficerJan 18 '24Sale3.713,12411,604117,576Jan 19 07:05 PM
Barton RussellChief Operating OfficerJan 18 '24Sale3.732,83310,55596,867Jan 19 07:04 PM
ERNA - Eterna Therapeutics Inc - Stock Price Chart
TickerERNA [NASD]
CompanyEterna Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap12.71MEPS (ttm)-4.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y0.06%
P/S181.62EPS next 5Y20.00%
P/B5.70EPS Q/Q-11.46%
Dividend-Sales Q/Q-
Insider Own48.42%Inst Own7.38%
Insider Trans0.00%Inst Trans-23.43%
Short Float1.23%Earnings-
Analyst Recom1.00Target Price60.00
Avg Volume8.36K52W Range0.84 - 2.99
May-10-24 08:00AM Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases (GlobeNewswire) -6.48%
May-08-24 09:31AM Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board (GlobeNewswire) +12.12%
May-07-24 08:00AM Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus (GlobeNewswire) +12.50%
08:00AM Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases (GlobeNewswire)
Mar-15-24 08:53AM ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q4 2023 (InvestorPlace)
Feb-20-24 08:30AM Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors (GlobeNewswire)
Jan-03-24 04:15PM Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4) (GlobeNewswire)
Dec-21-23 11:18AM Eterna Therapeutics Appoints Sanjeev Luther as President and CEO (Exec Edge)
Dec-20-23 04:15PM Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer (GlobeNewswire) +9.87%
Dec-14-23 06:56PM Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing (GlobeNewswire) +29.29%
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.
RAIL - FreightCar America Inc - Stock Price Chart
TickerRAIL [NASD]
CompanyFreightCar America Inc
CountryUSA
IndustryRailroads
Market Cap71.47MEPS (ttm)-1.48
P/E-EPS this Y146.15%
Forward P/E10.19EPS next Y108.33%
PEG-EPS past 5Y18.51%
P/S0.16EPS next 5Y3.00%
P/B-EPS Q/Q-184.14%
Dividend-Sales Q/Q98.84%
Insider Own32.82%Inst Own30.63%
Insider Trans0.55%Inst Trans-0.94%
Short Float1.08%EarningsMay 08/a
Analyst Recom3.00Target Price4.50
Avg Volume47.22K52W Range2.25 - 4.26
FreightCar America, Inc. engages in the manufacture of railcars and railcar components. It operates through the Manufacturing and Corporate and Other segments. The Manufacturing segment includes new railcar manufacturing, used railcar sales, railcar leasing and major railcar rebuilds. The Corporate and Other segment focuses on the sales of parts. The company was founded in 1901 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gil Benavides Jesus SalvadorDirectorApr 09 '24Option Exercise2.43317,022768,811345,794Apr 11 03:16 PM
Gil Benavides Alejandro10% OwnerDec 14 '23Buy2.4421,40052,216180,000Dec 20 04:17 PM
De Nigris Felan JoseDirectorMay 16 '23Buy3.0010,00030,00048,739May 17 04:41 PM
Meyer James RPresident and CEOMay 15 '23Buy2.9512,42736,66017,327May 16 04:27 PM
11011121314151617181920